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Objective: To study clinical factors predicting the absence of endocervical/transformation zone (EC/TZ)
components of conventional cervical Papanicolaou (Pap) smears.
Materials and methods: The medical charts of patients who received Pap smears between March 2006
and August 2006 in the hospital were reviewed. The results of their Pap smears were retrieved while
their demographic and clinical information were obtained from the medical charts. After excluding 378
cases with incomplete demographic data and 1397 cases with a history of pelvic irradiation, pelvic
malignancy, and hysterectomy, 5662 cases were enrolled for data analysis. The relationship between
clinical parameters and the absence of EC/TZ component was analyzed by Pearson Chi-square tests with
Yates continuity correction and binary logistic regression tests.
Results: The incidence of satisfactory but absence of EC/TZ component was 8.7% (491/5662). Pregnancy
increased the absence of EC/TZ component [odds ratio (OR}: 2.84, 95% conﬁdence interval (CI): 2.14e3.77,
p< 0.0001]. Postpartum status and endocervical polyps decreased incidence (OR: 0.61, 95% CI: 0.38e0.98,
p ¼ 0.043 and OR: 0.33, 95% CI: 0.25e0.44, p< 0.0001, respectively).
Conclusions: Pregnancy is the only clinical factor associated with increased incidence of absence of EC/TZ
cells. For these pregnant women undergoing a Pap smear, a more effective strategy may be needed to get
a satisfactory smear with adequate EC/TZ components.
Copyright © 2016, Taiwan Association of Obstetrics & Gynecology. Published by Elsevier Taiwan LLC. This
is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/
4.0/).Introduction
In the 1988 Bethesda System, specimen adequacy of a Papani-
colaou (Pap) smear includes one category called less than optimal,
which indicates that the smear provides useful diagnostics and Gynecology, Taichung
tion 3, Taichung City 40705,
.
bstetrics & Gynecology. Published binformation but is less than optimal due to obscurity caused by
inﬂammation, absence of endocervical cells, endocervical mucus,
or squamous metaplastic cells [1]. The terminology has since been
revised to satisfactory for evaluation but limited by in the 1991
Bethesda system [2]. In the 2001 Bethesda system, the terminology
is eliminated and replaced by presence or absence of endocervical or
transformation zone [EC/TZ] components or other quality indicators
such as partially obscuring blood or inﬂammation [3]. From the
report of the Cervical Cancer Screening Registration System of the
Health Promotion Administration, Ministry of Health and Welfare,y Elsevier Taiwan LLC. This is an open access article under the CC BY-NC-ND license
Table 1
Predictive factors for satisfactory but absence of endocervical/transformation compo-
nent by univariate analysis.
Variables Absence (n) Reference (n) p
Age < 0.0001
 50 y 64 (3.8) 1618 (96.2)
< 50 y 427 (11.5) 3301 (88.5)
Menopause < 0.0001
Yes 37 (2.6) 1397 (97.4)
No 454 (11.4) 3522 (88.6)
S/p Conization 0.084
Yes 26 (6.5) 371 (93.5)
No 465 (9.3) 4548 (90.7)
Pregnancy < 0.0001
Yes 78 (25.7) 226 (74.3)
No 413 (8.1) 4693 (91.9)
Within 3 mo PP 0.254
Yes 19 (7.0) 254 (93.0)
No 472 (9.2) 4665 (90.8)
Vaginal bleeding 0.595
Yes 32 (10.1) 286 (89.9)
No 459 (9.0) 4633 (91.0)
Abnormal discharge 0.513
Yes 36 (8.1) 408 (91.9)
No 455 (9.2) 4511 (90.8)
IUD insertion 0.865
Yes 16 (9.8) 148 (90.2)
No 75 (9.1) 4771 (90.9)
Endocervical polyps 0.080
Yes 4 (3.8) 102 (96.2)
No 487 (9.2) 4817 (90.8)
PP ¼ postpartum; Absence ¼ satisfactory Pap smear but absence of endocervical/
transformation zone component; N ¼ number; Reference ¼ satisfactory Pap smear,
including clear demonstration of endocervical/transformation zone component.
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including 35.9% that were due to the absence of EC/TZ cells. This
means that 9.2% of all Pap smears are satisfactory but without EC/TZ
cells. Thus, this issue has a signiﬁcant impact on a large portion of
the population who receive Pap smear examinations and to phy-
sicians who take the smears.
The absence of EC/TZ components was initially found to
decrease the sensitivity of detecting epithelial abnormalities and
even cervical cancers [5e8]. Later studies that used better study
designs and even larger populations failed to establish an associa-
tion between the lack of endocervical cells and the increased inci-
dence of high-grade diseases or cervical cancers [9,10]. There are
currently no randomized trials or meta-analyses on this issue [11].
For patients with a negative smear and absence of EC/TZ com-
ponents, the American Society for Colposcopy and Cervical Pa-
thology suggests repeat Pap smear in 12 months. In cases with a
history of minor cervical abnormalities or inadequate smear history
or procedures, repeat smear within 6 months is beneﬁcial [12]. The
impact of the absence of endocervical cells is immense to both
patients and doctors. However, the clinical conditions associated
with absence of EC/TZ cells have never been studied. Therefore, this
retrospective study was designed to explore the clinical conditions
associated with absence of EC/TZ cells.
Materials and methods
The materials and methods used here had been published in
previous studies [13,14]. The Institutional Review Board of Taichung
Veterans General Hospital approved the study. Patients who
received conventional Pap smears betweenMarch 2006 and August
2006 were enrolled. The results of their Pap smear were retrieved
from the Department of Pathology and Laboratory Medicine. Their
demographic and clinical information were obtained from their
medical charts, as recorded by the attending physicians who took
the Pap smears.
In terms of the whole procedure of Pap smear examination, the
cervical smears were taken with Ayre's spatulas, endocervical
cytobrushes, or a combination with attempts to scrub the whole
transformation zone. Findings of pelvic examination were also
recorded. The smears were ﬁxed in separate bottles of 95% alcohol
for ﬁxation, stained using the Papanicolaou technique, screened by
qualiﬁed cytotechnologists under light microscopy, and then re-
screened by a cytopathologist before the formal reports.
In the study period, 7437 Pap smears were taken. After
excluding 378 cases due to incomplete demographic data, 7059
cases were included. Their data on history of pelvic malignancy
(excluding microinvasive carcinoma of cervix), systemic chemo-
therapy, pelvic irradiation, cervical conization (including cold knife
cone, loop electro-surgical excision procedure, and needle cone),
hysterectomy (total abdominal hysterectomy, total vaginal hyster-
ectomy, laparoscopic-assisted vaginal hysterectomy, modiﬁed
radical hysterectomy, and radical hysterectomy), pregnancy, within
3 months postpartum (>20 gestational weeks), vaginal bleeding or
spotting, abnormal vaginal discharge (suggestive of infection or
foreign body reaction), intrauterine device, and endocervical
polyps were obtained. After further excluding 1397 cases with a
history of either pelvic irradiation, systemic chemotherapy, pelvic
malignancy, or hysterectomy [13], 5662 cases were enrolled for
data analysis.
The relationship between clinical parameters with satisfactory
but absence of EC/TZ componentwas analyzed by Pearson Chi-square
tests with Yates continuity correction and binary logistic regression
tests for signiﬁcance analysis. Statistical signiﬁcance was set at
p  0.05. Data were analyzed using SPSS software (SPSS for Win-
dows, version 12.0; SPSS Inc., Chicago, IL, USA).Results
Some detailed demographic characteristics and quality and re-
sults of the Pap smears of the cohort were published before and the
parts relevant to this study summarized [13,14]. The median age of
the cohort was 44.5 years (range, 15e93 years). Median gravidity
was 2.7 (range, 0e15), and median parity was 1.9 (range, 0e12).
Of the 5662 patients enrolled in ﬁnal analysis, specimen ade-
quacy was satisfactory in 4919 (86.9%), satisfactory but absence of
EC/TZ component in 491 (8.7%), and unsatisfactory for evaluation in
252 (4.5%). The incidence of abnormal Pap smears equals to or
greater than atypical cells was 4.53%.
On an attempt to explore the clinical factors by univariate
analysis, only pregnancy was associated with increased incidence
of satisfactory but absence of EC/TZ component (Table 1). Among the
304 pregnant women who received Pap smears in the hospital, 78
(25.6%) had satisfactory but absence of EC/TZ component. By contrast,
age > 50 years and menopause were associated with lower inci-
dence of absence of EC/TZ component.
When these parameters were further analyzed by multivariate
binary logistic regression test, pregnancy was found to be signiﬁ-
cantly associated with more satisfactory but absence of EC/TZ
component [odds ratio (OR): 2.84, 95% conﬁdence interval (CI): 2.14-
3.77, p< 0.0001; Table 2]. However, within 3 months postpartum
and the presence of endocervical polyps were associated with a
lower incidence (OR: 0.61, 95% CI: 0.38e0.98, p ¼ 0.043; and OR:
0.33, 95% CI: 0.25e0.44, p< 0.0001, respectively; Table 2).
Discussion
Given the proportion of absence of EC/TZ component in a large
population receiving Pap smears, correct management must be re-
emphasized [4]. According to the American Society for Colposcopy
and Cervical Pathology guidelines [15], women with a routine Pap
Table 2
Relationship between clinical factors with satisfactory but absence of endocervical/
transformation zone component, by multivariate binary analysis.
Variables OR (95% CI) p
Age  50 y 0.42 (0.15e1.15) 0.090
S/p conization 0.71 (0.47e1.07) 0.103
Pregnancy 2.84 (2.14e3.77) < 0.0001
Within 3-month postpartum 0.61 (0.38e0.98) 0.043
Vaginal bleeding 1.09 (0.74e1.61) 0.652
Abnormal discharge 0.84 (0.59e1.20) 0.340
IUD insertion 1.05 (0.62e1.79) 0.858
Endocervical polyps 0.33 (0.25e0.44) < 0.0001
95% CI ¼ 95% conﬁdence interval; IUD ¼ intrauterine device; OR ¼ odds ratio;
S/p ¼ post status.
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up. Early follow-up at 6-month intervals may be beneﬁcial to
women with certain conditions, which include previous abnormal
squamous or glandular abnormalities, positive high-risk human
papilloma virus tests, inadequate screening history and sampling
process, and repeated, obscuring factors causing the absence of
EZ/TZ components.
Although recent retrospective studies reveal no association be-
tween the lack of EC/TZ components and increased incidence of
high-grade disease or cervical cancer [9,10], whether this condition
will cause false negatives in the screening for glandular dysplasia or
adenocarcinoma is another concern [16]. In a longitudinal analysis
of Pap smear results using statewide database at 36-month in-
tervals in Australia, Mitchell [10] found six cases of adenocarcinoma
or adenocarcinoma in situ in the cohort with two Pap smear both
with presence of EC/TZ cells and four cases of adenocarcinoma or
adenocarcinoma in situ in the cohort with absence and presence of
EC/TZ. One case of adenocarcinoma was diagnosed in the presence/
absence cohort, but none in the absence/absence cohort. Although
there was insufﬁcient statistical power due to the scarcity of cases
in the cohort, there was a trend that the presence of EC/TZ cells
helped screen out glandular abnormalities.
Most glandular lesions arise from the columnar (endocervical)
portion of the cervical epithelium. Theoretically, the inability to
collect EC/TZ cells may decrease the sensitivity for detecting glan-
dular abnormalities. This may be a potential loophole in population
screening programs for cervical cancer prevention. From data of
countries that provide population screening, the incidence of
squamous cell carcinoma of the cervix is decreased by nearly 70%
after 30e50 years of cervical cytology screening [17e20]. However,
from reports of different countries, the incidence of adenocarci-
noma and adenosquamous carcinoma has reached a plateau or is
still increasing [20e23]. This disparity may be partly due to the
lower sensitivity in detecting glandular abnormalities than squa-
mous abnormalities [24]. Failure to collect EC/TZ cells due to
technical or instrument problems may also play a role in lowering
sensitivity. From this viewpoint, collecting EC/TZ cells during cer-
vical sampling is still strongly recommended.
Under the inﬂuence of large amounts of estrogen and proges-
terone during pregnancy, the cervix undergoes numerous and
variable physiologic changes. However, tissue edema, copious
mucus production, frequent inﬂammation, and confusing decidual
cells often complicate the sampling and interpretation of cytology
in pregnancy [25]. Although pregnancy induces cervical ectropion
that represents eversion of the squamocolumnar junction, preg-
nancy is associated with the lack of endocervical cells on cervico-
vaginal cytology. Kruger et al reported that endocervical cell
recovery rate was lower during pregnancy than during non-
pregnancy (60e65% vs. 85%) [26]. Kost et al had similar ﬁndings
[27]. Thus, strategies should be developed to collect more endo-
cervical cells during Pap smears in pregnant women.Paraiso et al. reported increased endocervical yield with both
the cytobrush and modiﬁed Ayers spatula (90.7%) and the Cervex-
Brush (83.3%) methods, compared to the cotton swab and modiﬁed
Ayre's spatula (70.8%) in pregnant women [28]. Stillson and Knight
also found that cytobrushespatula yielded more endocervical cell
during pregnancy [29]. The explanation for the lower EC/TZ
component collection during pregnancy is the thick tenacious
cervical mucus barriers during pregnancy. Another explanation is
the lesser cytobrush use, with the assumption that the collection
device will increase the rate of premature rupture of membrane
and the spatula itself is enough for cervical epithelial cell collection.
Based on the characteristics of the retrospective study, all of them
need further conﬁrmation and the strategy can be used to increase
EC/TZ component collection in the satisfactory Pap smear.
After placental expulsion and hormonal withdrawal, the cervical
ectropion is usually not regressed, but the cervical mucosa is
atropic [30]. The relationship between specimen adequacy and
postpartum status has not been previously studied. The absence of
EC/TZ component occurs signiﬁcantly less among postpartum
women in this study, which can be explained by the grossly
ectropic cervix but no coating mucus as seen in pregnancy. This
facilitates EC/TZ cell collection.
Endocervical polyps are a focal hyperplasia of the glandular
epithelium of the endocervix that contains a glandular structure
with a ﬁbrous core [31]. The relationship between endocervical
polyps and the adequacy of Pap smear has not been previously
studied. This study shows that the presence of endocervical
polyp(s) signiﬁcantly decreases the incidence of absence of EC/TZ
cells (relative risk 0.33). This can be explained by the nature and
causes of endocervical polyps, which are hyperplasia of endocer-
vical glands. Thus, obtaining endocervical cells is easier.
Aging and conization may both cause synechiae and even cer-
vical stenosis. It may be expected that these conditions will in-
crease the incidence of absence of EC/TZ component [32,33].
However, from this research, age 50 years and conization are both
associated with less absence of EC/TZ component, although this was
not statistically signiﬁcant. This may be due to the retrospective
data analysis. The sampling devices used are chosen by the
attending physicians for the purpose to collect cervical cytology
with the best quality. These well-trained specialists are more
familiar with the anatomic limitations of the cervix and will pref-
erentially use a cytobrush instead of a spatula in cervical cell
sampling. Thus, the incidence of absence of EC/TZ component is
decreased compared to the entire cohort.
This study is limited by the relatively low incidence of satisfac-
tory but absence of EC/TZ component smears. This limitation can be
compensated by the use of multivariate logistic regression test. The
bias of tertiary medical center-based study may also be counter-
acted by the methods of analysis. Limitations also come from the
nature of retrospective cross-sectional studies. Potential bias may
come from collection devices used and judgment of vaginal
discharge and vaginal bleeding. Medical chart record as the source
of data is another potential cause of bias. Such biases can be
partially attenuated by the fact that Pap smears are routinely taken
by experienced attending physicians, who also made the medical
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